VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
TALKTalkspace, Inc.
$5.21$873M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksTALKP/E History

TALK logoTalkspace, Inc. (TALK) P/E Ratio History

Undervalued

Trading at 130.3x vs 5Y avg 356.3x · 20th percentile · Below historical baseline · Data 2021–2026

Current P/E (TTM)
130.3x
-63% vs 5Y avg
5Y Avg P/E
356.3x
Median 202.3x
5Y Percentile
20th
Lower end of range
PEG Ratio
N/A
5-Year P/E Range
130.3x
Min80.1xMedian202.3xMax1478.6x
TTM EPS$0.01
Price$5.21
Earnings Yield0.77%
EPS Growth (1Y)N/A
EPS Growth (5Y)N/A

Loading P/E history...

P/E Ratio Analysis

As of June 22, 2026, Talkspace, Inc. (TALK) trades at a price-to-earnings ratio of 130.3x, with a stock price of $5.21 and trailing twelve-month earnings per share of $0.01.

The current P/E is 63% below its 5-year average of 356.3x. Over the past five years, TALK's P/E has ranged from a low of 80.1x to a high of 1478.6x, placing the current valuation at the 20th percentile of its historical range.

Compared to the Healthcare sector median P/E of 22.1x, TALK trades at a 489% premium to its sector peers. The sector includes 234 companies with P/E ratios ranging from 0.0x to 197.0x.

Relative to the broader market, TALK commands a significant premium over the S&P 500 median P/E of 24.4x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.

For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our TALK DCF Valuation Calculator →

Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.

TALK Cross-Benchmark Valuation

How does the current P/E compare to sector peers and the broader market?

vs. Healthcare
130.3vs22.1
+489%
Above Sector
vs. S&P 500
130.3vs24.4
+433%
Above Market
PEG Analysis
N/A
P/E ÷ EPS Growth

TALK P/E vs Peers

Virtual and consumer health clinics peers sorted by market cap

CompanyMarket CapP/E RatioPEG RatioEPS Growth (1Y)
OPRX logoOPRXOptimizeRx Corporation
$93M18.4Lowest-+125%Best
ACMR logoACMRACM Research, Inc.
$7B80.22.26-10%
DOCS logoDOCSDoximity, Inc.
$4B20.90.40Best-12%
HIMS logoHIMSHims & Hers Health, Inc.
$8B69.5--4%
GDRX logoGDRXGoodRx Holdings, Inc.
$922M31.2-+104%
UNH logoUNHUnitedHealth Group Incorporated
$364B30.3--15%

Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.

TALK Historical P/E Data (2021–2026)

Quarterly P/E ratios calculated from closing price and TTM EPS

QuarterPeriod EndPriceTTM EPSP/E Ratiovs Avg
FY2026 Q1-$5.17$0.001478.6x+315%
FY2025 Q4Dec 31 2025$3.63$0.0580.1x-78%
FY2025 Q3-$2.76$0.02112.7x-68%
FY2025 Q2Jun 30 2025$2.78$0.02172.7x-52%
FY2025 Q1Mar 31 2025$2.56$0.02155.2x-56%
FY2024 Q4-$3.09$0.01515.0x+45%
FY2022 Q2-$1.70$0.01193.2x-46%
FY2022 Q1-$1.74$0.01202.3x-43%
FY2021 Q4Dec 31 2021$1.97$0.01229.1x-36%
FY2021 Q3-$3.65$0.01424.4x+19%

Average P/E for displayed period: 356.3x

Export Data
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

5+ years return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

TALK — Frequently Asked Questions

Quick answers to the most common questions about buying TALK stock.

What is TALK's P/E ratio?

Talkspace, Inc. (TALK) trailing twelve-month P/E ratio is 130.3x, based on TTM diluted EPS of $0.01. The 5-year average P/E is 356.3x and the historical range spans 80.1x to 1478.6x.

Is TALK stock overvalued or undervalued?

TALK trades at 130.3x P/E, below its 5-year average of 356.3x. At the 20th percentile of its historical range (80.1x–1478.6x), the stock is priced at a discount to its own history.

Is TALK stock expensive?

No, TALK is not expensive on a historical basis. The current P/E of 130.3x is below the 5-year average of 356.3x and sits at the 20th percentile of its valuation range.

What is TALK's historical P/E range?

Over the past 5 years, TALK's P/E ratio has ranged from 80.1x to 1478.6x, with a median of 202.3x and an average of 356.3x. The current P/E of 130.3x places the stock at the 20th percentile of this range. Full historical data spans 2021–2026.

How does TALK's P/E compare to the S&P 500?

TALK trades at 130.3x P/E versus the S&P 500 median of 24.4x. The 434% premium to the market typically reflects higher expected earnings growth or quality.

How does TALK's valuation compare to Healthcare peers?

Talkspace, Inc. P/E of 130.3x compares to the Healthcare sector median of 22.1x. The premium reflects expected growth above peers or stronger fundamentals. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.

What is TALK's PEG ratio?

TALK PEG ratio is N/A. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.

What is TALK's earnings yield?

TALK earnings yield is 0.77%, the inverse of its 130.3x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.

TALK P/E Ratio History (2021–2026)

Quarterly valuation multiple from closing price and trailing EPS

Current1478.6x
Period Avg356.3x
Range80.1x - 1478.6x
Change+248%
10 quartersSep 30, 2021 - Mar 31, 2026